Works matching IS 10584838 AND DT 2014 AND VI 59 AND IP 12


Results: 39
    1

    Editorial Board.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. NP, doi. 10.1093/cid/cit839
    Publication type:
    Article
    2
    3

    Virologic Resistance Analysis From a Phase 2 Study of MK-5172 Combined With Pegylated Interferon/Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1657, doi. 10.1093/cid/ciu696
    By:
    • Howe, Anita Y. M.;
    • Black, Stuart;
    • Curry, Stephanie;
    • Ludmerer, Steven W.;
    • Liu, Rong;
    • Barnard, Richard J. O.;
    • Newhard, William;
    • Hwang, Peggy M. T.;
    • Nickle, David;
    • Gilbert, Christopher;
    • Caro, Luzelena;
    • DiNubile, Mark J.;
    • Mobashery, Niloufar
    Publication type:
    Article
    4

    Increased Coronary Vessel Wall Thickness in HIV-Infected Young Adults.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1779, doi. 10.1093/cid/ciu672
    By:
    • Abd-Elmoniem, Khaled Z.;
    • Unsal, Aylin B.;
    • Eshera, Sarah;
    • Matta, Jatin R.;
    • Muldoon, Nancy;
    • McAreavey, Dorothea;
    • Purdy, Julia B.;
    • Hazra, Rohan;
    • Hadigan, Colleen;
    • Gharib, Ahmed M.
    Publication type:
    Article
    5
    6

    Subscriptions Page.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. NP, doi. 10.1093/cid/cit887
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Masthead.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. NP, doi. 10.1093/cid/ciu951
    Publication type:
    Article
    15
    16

    Cover.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. NP, doi. 10.1093/cid/cit863
    Publication type:
    Article
    17

    15 December News.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. i, doi. 10.1093/cid/ciu824
    Publication type:
    Article
    18

    In the Literature.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. iii, doi. 10.1093/cid/ciu817
    Publication type:
    Article
    20
    21

    Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1798, doi. 10.1093/cid/ciu674
    By:
    • Narendran, Gopalan;
    • Menon, Pradeep Aravindan;
    • Venkatesan, Perumal;
    • Vijay, Krishnamoorthy;
    • Padmapriyadarsini, Chandrasekaran;
    • Ramesh Kumar, Santhanakrishnan;
    • Bhavani, Kannabiran Perumal;
    • Sekar, Lakshmanan;
    • Gomathi, Sivaramakrishnan Narayan;
    • Chandrasekhar, Chockalingam;
    • Kumar, Satagopan;
    • Sridhar, Rathinam;
    • Swaminathan, Soumya
    Publication type:
    Article
    22

    Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1666, doi. 10.1093/cid/ciu697
    By:
    • Svarovskaia, Evguenia S.;
    • Dvory‐Sobol, Hadas;
    • Parkin, Neil;
    • Hebner, Christy;
    • Gontcharova, Viktoria;
    • Martin, Ross;
    • Ouyang, Wen;
    • Han, Bin;
    • Xu, Simin;
    • Ku, Karin;
    • Chiu, Sophia;
    • Gane, Edward;
    • Jacobson, Ira M.;
    • Nelson, David R.;
    • Lawitz, Eric;
    • Wyles, David L.;
    • Bekele, Neby;
    • Brainard, Diana;
    • Symonds, William T.;
    • McHutchison, John G.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    Reply to Worth et al.

    Published in:
    2014
    By:
    • Mitchell, Brett G.;
    • Collignon, Peter J.;
    • McCann, Rebecca;
    • Wilkinson, Irene J.;
    • Wells, Anne
    Publication type:
    Letter to the Editor
    32
    33

    Editorial Advisory Board.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. NP, doi. 10.1093/cid/ciu950
    Publication type:
    Article
    34

    Telaprevir for HIV/Hepatitis C Virus–Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1768
    By:
    • Cotte, Laurent;
    • Braun, Joséphine;
    • Lascoux-Combe, Caroline;
    • Vincent, Corine;
    • Valantin, Marc-Antoine;
    • Sogni, Philippe;
    • Lacombe, Karine;
    • Neau, Didier;
    • Aumaitre, Hugues;
    • Batisse, Dominique;
    • de Truchis, Pierre;
    • Gervais, Anne;
    • Michelet, Christian;
    • Morlat, Philippe;
    • Vittecoq, Daniel;
    • Rosa, Isabelle;
    • Bertucci, Inga;
    • Chevaliez, Stéphane;
    • Aboulker, Jean-Pierre;
    • Molina, Jean-Michel
    Publication type:
    Article
    35
    36
    37

    Reviewers.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. e165, doi. 10.1093/cid/ciu903
    Publication type:
    Article
    39